Literature DB >> 24398820

Rimonabant's reductive effects on high densities of food reinforcement, but not palatability, in lean and obese Zucker rats.

Jessica L Buckley1, Erin B Rasmussen.   

Abstract

RATIONALE: Cannabinoid antagonists purportedly have greater effects in reducing the intake of highly palatable food compared to less palatable food. However, this assertion is based on free-feeding studies in which the amount of palatable food eaten under baseline conditions is often confounded with other variables, such as unequal access to both food options and differences in qualitative features of the foods.
OBJECTIVE: We attempted to reduce these confounds by using a model of choice that programmed the delivery rates of sucrose and carrot-flavored pellets.
METHODS: Lever pressing of ten lean (Fa/Fa or Fa/fa) and ten obese (fa/fa) Zucker rats was placed under three conditions in which programmed ratios for food pellets on two levers were 5:1, 1:1, and 1:5. In phase 1, responses on the two levers produced one type of pellet (sucrose or carrot); in phase 2, responses on one lever produced sucrose pellets and on the other lever produced carrot pellets. After responses stabilized under each food ratio, acute doses of rimonabant (0, 3, and 10 mg/kg) were administered before experimental sessions. The number of reinforcers and responses earned per session under each ratio and from each lever was compared. RESULTS AND
CONCLUSIONS: Rimonabant reduced reinforcers in 1:5 and 5:1 food ratios in phase 1, and across all ratios in phase 2. Rimonabant reduced sucrose and carrot-flavored pellet consumption similarly; rimonabant did not affect bias toward sucrose, but increased sensitivity to amount differences in lean rats. This suggests that relative amount of food, not palatability, may be an important behavioral mechanism in the effects of rimonabant.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24398820      PMCID: PMC4036064          DOI: 10.1007/s00213-013-3366-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

1.  SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.

Authors:  J Simiand; M Keane; P E Keane; P Soubrié
Journal:  Behav Pharmacol       Date:  1998-03       Impact factor: 2.293

2.  Relative and absolute strength of response as a function of frequency of reinforcement.

Authors:  R J HERRNSTEIN
Journal:  J Exp Anal Behav       Date:  1961-07       Impact factor: 2.468

3.  The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food.

Authors:  Zoë D Thornton-Jones; Steven P Vickers; Peter G Clifton
Journal:  Psychopharmacology (Berl)       Date:  2004-11-18       Impact factor: 4.530

4.  On two types of deviation from the matching law: bias and undermatching.

Authors:  W M Baum
Journal:  J Exp Anal Behav       Date:  1974-07       Impact factor: 2.468

5.  Concurrent schedule assessment of food preference in cows.

Authors:  L R Matthews; W Temple
Journal:  J Exp Anal Behav       Date:  1979-09       Impact factor: 2.468

6.  Matching, undermatching, and overmatching in studies of choice.

Authors:  W M Baum
Journal:  J Exp Anal Behav       Date:  1979-09       Impact factor: 2.468

7.  Effects of 2-AG on the reinforcing properties of wheel activity in obese and lean Zucker rats.

Authors:  Shilo L Smith; Erin B Rasmussen
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

8.  Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats.

Authors:  Clare M Mathes; Marco Ferrara; Neil E Rowland
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-30       Impact factor: 3.619

9.  Effects of rimonabant on behavior maintained by progressive ratio schedules of sucrose reinforcement in obese Zucker (fa/fa) rats.

Authors:  Erin B Rasmussen; Sally L Huskinson
Journal:  Behav Pharmacol       Date:  2008-10       Impact factor: 2.293

10.  Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.

Authors:  S P Vickers; L J Webster; A Wyatt; C T Dourish; G A Kennett
Journal:  Psychopharmacology (Berl)       Date:  2003-03-11       Impact factor: 4.530

View more
  5 in total

Review 1.  The utility of behavioral economics in expanding the free-feed model of obesity.

Authors:  Erin B Rasmussen; Stephen H Robertson; Luis R Rodriguez
Journal:  Behav Processes       Date:  2016-02-23       Impact factor: 1.777

2.  Corn oil, but not cocaine, is a more effective reinforcer in obese than in lean Zucker rats.

Authors:  Edward A Townsend; Lauren N Beloate; Sally L Huskinson; Peter G Roma; Kevin B Freeman
Journal:  Physiol Behav       Date:  2015-03-03

3.  Interrelationship of CB1R and OBR pathways in regulation of metabolic, neuroendocrine, and behavioral responses to food restriction and voluntary wheel running.

Authors:  Abdoulaye Diane; Donna F Vine; James C Russell; C Donald Heth; W David Pierce; Spencer D Proctor
Journal:  J Appl Physiol (1985)       Date:  2014-06-05

4.  Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standard-chow diets.

Authors:  Steven R Boomhower; Erin B Rasmussen
Journal:  Behav Pharmacol       Date:  2014-12       Impact factor: 2.293

Review 5.  Peptides from Natural or Rationally Designed Sources Can Be Used in Overweight, Obesity, and Type 2 Diabetes Therapies.

Authors:  Mayara C F Gewehr; Renata Silverio; José Cesar Rosa-Neto; Fabio S Lira; Patrícia Reckziegel; Emer S Ferro
Journal:  Molecules       Date:  2020-02-29       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.